Full text
Earnings transcript
Read the complete earnings call transcript.
LRCX
Lam Research Corporation
$230.18
0.03
(0.01%)
| Exchange: | NASDAQ |
| Market Cap: | 288.052B |
| Shares Outstanding: | 340M |
Delayed data
About The Company
| Sector: | TechnologyView sector performance | |||||
| Industry: | SemiconductorsView industry performance | |||||
| CEO: | Timothy Archer | |||||
| Full Time Employees: | 23300 | |||||
| Address: |
| |||||
| Website: | https://www.lamresearch.com |
Lam Research Corporation is a prominent supplier of equipment vital for semiconductor processing, encompassing its design, production, sales, repair, and ongoing maintenance. These sophisticated systems are fundamental for the creation of integrated circuits. The company’s extensive product catalog features a variety of deposition technologies. For tungsten metallization, they provide ALTUS systems that deposit conformal films. SABRE products excel in electrochemical deposition, crucial for copper interconnect transitions and enabling copper damascene manufacturing. SOLA utilizes ultraviolet thermal processing for film treatments, while VECTOR delivers plasma-enhanced chemical vapor deposition (CVD) and atomic layer deposition (ALD) solutions. Furthermore, SPEED addresses gapfill applications with its high-density plasma CVD products, and Striker is engineered for single-wafer atomic layer deposition of dielectric films. Beyond deposition, Lam Research offers a comprehensive suite of etching tools. Flex is designed for dielectric etch applications, Kiyo handles conductor etch processes, Syndion specializes in through-silicon via etching, and Versys metal products are used for metal etch processes. The company’s offerings also extend to specialized solutions like Coronus, which enhances die yield through bevel cleaning. For various wafer cleaning requirements, Lam Research supplies multiple product lines, including Da Vinci, DV-Prime, EOS, and SP series. Additionally, Metryx mass metrology systems provide precise, in-line mass measurement capabilities for semiconductor wafer manufacturing. Lam Research serves the global semiconductor industry, distributing its technologies and services across the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and other international markets. Established in 1980, the company maintains its corporate headquarters in Fremont, California.
Click to read more…
Revenue Segmentation
LRCX full analysis
Welcome back to MarketSnap. Lam Research reported after the close on Wednesday — record revenue, record gross margin, record earnings per share, and guidance for the December quarter even higher. And the stock fell almost 12% on Thursday. It's now down about 28% over three months, and it sits below the $250 to $260 level we said back in February we'd wait for before adding. So the pullback arrived. The question is whether it's the one we wanted, or whether…
Industry Peers
| TICKER | COMPANY | MKT CAP | P/E | FWD P/E | ROIC |
|---|---|---|---|---|---|
| LRCX | Lam Research Corporation | 288.1B | 45.6 | 40.4 | 40.8% |
 AMAT | Applied Materials, Inc. | 299.9B | 35.1 | 29.5 | 23.5% |
 TXN | Texas Instruments Incorporated | 259.4B | 41.8 | 31.5 | 18.8% |
 ARM | Arm Holdings plc American Depositary S… | 224.7B | 235 | 89.9 | 7.3% |
 MRVL | Marvell Technology, Inc. | 199.8B | 74.7 | 80.3 | 5.4% |
 KLAC | KLA Corporation | 189.7B | 45.0 | 39.2 | 35.6% |
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 14,905,386 | 18,435,591 | 23,232,690 |
| Gross Profit | 7,052,791 | 8,979,059 | 11,725,308 |
| EBITDA | 4,905,157 | 6,344,406 | 8,704,006 |
| Operating Income | 4,263,913 | 5,900,968 | 8,199,795 |
| Net Income | 3,827,772 | 5,358,217 | 7,265,396 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Total Assets | 18,744,728 | 21,345,260 | 23,529,743 |
| Total Liabilities | 10,205,274 | 11,483,641 | 11,058,822 |
| Total Stockholders Equity | 8,539,454 | 9,861,619 | 12,470,921 |
| Total Debt | 4,983,334 | 4,484,505 | 3,734,563 |
| Cash and Cash Equivalents | 5,847,856 | 6,390,659 | 5,579,171 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Operating Cash Flow | 4,652,269 | 6,173,264 | 5,857,657 |
| Capital Expenditure | -396,670 | -759,186 | -966,405 |
| Free Cash Flow | 4,255,599 | 5,414,078 | 4,891,252 |
| Net Income | 3,827,772 | 5,358,217 | 7,265,396 |
| Net Change in Cash | 263,431 | 556,853 | -809,713 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2031 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 53,505,436.642 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 66,908,945.420 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 60,284,200 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 24,129,802.064 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 31,817,381.697 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 28,017,760.928 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 20,102,974.777 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 26,908,373.004 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 23,544,774.358 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 2,784,276.196 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 3,481,758.037 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 3,137,024.452 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 18.670 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 21.340 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 15.940 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 6 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 4 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Record financial performance: FY2026 revenue reached $23.23B (up ~26% YoY from $18.44B), net income $7.27B (up ~36%), and EPS $5.79 vs. $4.17. Q1 FY2027 marked record revenue, profitability, and EPS, driven by AI, advanced semiconductor manufacturing, and packaging demand for deposition and etch equipment.
- Exceptional profitability and balance sheet quality: TTM gross margin 50.5%, net margin 31.3%, ROE 67.0%, ROIC 40.8%, current ratio 2.63, quick ratio 1.91, and debt-to-equity of just 0.33. FY2026 free cash flow of $4.89B funds $1.27B in dividends while reducing liabilities.
- Growth product traction: Cumulative Aether dry resist revenue expected to reach $2.5B, and the Customer Support Business Group is guided to grow over 30% annually—a recurring, less cyclical revenue layer (FY2026 Customer Support and Other segment: $8.35B of $23.23B total).
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MarketSnap estimates LRCX intrinsic value between $215.67 – $225.53 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about LRCX valuation
Is Lam Research Corporation (LRCX) overvalued or undervalued right now?
MarketSnap estimates intrinsic value for Lam Research Corporation (LRCX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is LRCX a buy, hold, or sell for long-term investors?
MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether LRCX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is LRCX’s P/E ratio?
You can see LRCX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for LRCX?
MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is LRCX a good long-term investment?
Whether LRCX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
LRCX
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
0.01
Trading Metrics:
| Open: | 227.03 | Previous Close: | 230.15 | |
| Day Low: | 225.14 | Day High: | 234.06 | |
| Year Low: | 135.5 | Year High: | 438.5 | |
| Price Avg 50: | 304.53 | Price Avg 200: | 283.29 | |
| Volume: | 8.391M | Average Volume: | 10.505M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
